- Gene Editing Market is mainly driven by the growing demand for gene editing tools from the biotechnology sector.
- The Americas is the highest market share holder in the global geographical segmentation.
- Gene editing is expected to gain significant traction from research and development.
Genetic modification has opened the doors for reverse genetics, linking of the DNA sequence to phenotype, and analyzing gene function. With traditional and conventional methods becoming obsolete due to its time-consuming, inefficient, and labor-intensive characteristics, it has led to the emergence of new technologies and methodologies.
Technologies such as TALEN, CRISPR /Cas9 nuclease, and ZFN boast the ability to initiate genome editing in a precise and easy manner with no limitations by the organism.
The global Gene Editing Market is mainly driven by growing demand for gene editing tools from the biotechnology sector, where gene editing is becoming an increasingly important tool for research of various kinds. The growing gene editing market is profiled in the report with the help of detailed information about the market’s historical growth trajectory. This information provides solid backing for the market’s likely growth trajectory from 2017 to 2023.
Gene editing is expected to gain significant traction from research and development due to increased investment in the sector. At the same time, the pharmaceutical sector is providing significant traction to the gene editing market to develop new drugs in a bid to counter chronic diseases. However, the prospect of the gene editing market could be threatened as it raises several moral questions and hence, a lot of stipulations have been imposed by several governments.
Key player in the market are Transposagen Biopharmaceuticals Inc, Thermo Fisher Scientific Inc, Sigma-Aldrich Corporation, Sangamo Biosciences Inc, OriGene Technologies Inc, New England Biolabs Inc, Lonza Group Ltd, and Integrated DNA Technologies Inc.
Buy Research Report: Ice Hockey Equipment Market to Grow 1.9X by 2030, Manufacturers to Prioritize Online Sales Channels
Buy Research Report: COVID-19 Inhibits Demand for Processed Meat amid Bottlenecks in Supply and Production
Buy Research Report: Oligonucleotide Synthesis Market on a Positive Growth Trajectory, Supported by Developments in Synthetic Chemistry, Projects
Buy Research Report: Global Advance Wound Care Market to Reach Nearly US$ 15 Billion by 2030
Buy Research Report: Sales of Isobutylene to Ride on Gas Permeability Quotient; Uptake by End-use Industries Limited by COVID-19 Outbreak
The global gene editing market is segmented on the basis of method, application, end use, and region. By application, the global gene editing market is segmented into plant genetic engineering, animal genetic engineering, microorganism genetic engineering, and gene therapy.
By method, the global gene editing market is segmented into CRISPR, TALEN, ZFN, antisense technology, and others. CRISPR holds by far the largest share in the global gene editing market, followed by TALEN. Further enhancements in CRISPR technology to make it even more precise and useful are likely to further increase the share of the segment in the coming years.
By end use, the global gene editing market is segmented into the biotech industry, the pharmaceutical industry, and contract research organizations.
The geographical market segmentation covers regions like Asia-Pacific, the Americas, Europe, and the Middle East & Africa.
The Americas is the highest market share holder in the global geographical segmentation. The US accounts for the largest contributor to the Americas market with huge development in drug discovery research, development of the biotechnology industry, infrastructural superiority in the healthcare industry, and many other factors.
Europe closely follows the Americas with the region placing more impetus on finding better treatment solutions with investments in advancing technologies. Asia-Pacific is expected to the be fastest growing market due to increasing support from the government to proliferate the biotechnology sector. Finally, lack of technical know-how, low level of development in the biotechnology industry is limiting the growth charts of the Middle East & Africa market.